Zhigui Su
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Drug Discovery top 10%
Papers in
- Biomaterials 28
- Nanoparticle-Based Drug Delivery 28
-
- Advanced Drug Delivery Systems 4
- Drug Solubulity and Delivery Systems 2
- Co-authors
- Qineng Neng Ping (28 shared papers)Can Zhang (18 shared papers)Lingjing Xue (14 shared papers)Minjie Sun (14 shared papers)Yanyu Xiao (18 shared papers)Minglei Chen (9 shared papers)Huipeng Li (5 shared papers)Yue Wu (5 shared papers)
In The Last Decade
Zhigui Su
57 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 61
- Biomaterials 846
- Drug Discovery 4
- Pharmaceutical Science 300
- Biomedical Engineering 285
- Molecular Medicine 44
Countries citing papers authored by Zhigui Su
This map shows the geographic impact of Zhigui Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhigui Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhigui Su more than expected).
Fields of papers citing papers by Zhigui Su
This network shows the impact of papers produced by Zhigui Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhigui Su. The network helps show where Zhigui Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhigui Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 166 | |
| 2 | 2015 | 161 | |
| 3 | 2019 | 144 | |
| 4 | 2014 | 140 | |
| 5 | 2015 | 120 | |
| 6 | 2014 | 112 | |
| 7 | 2014 | 110 | |
| 8 | 2016 | 109 | |
| 9 | 2014 | 106 | |
| 10 | 2010 | 105 | |
| 11 | 2016 | 88 | |
| 12 | 2017 | 85 | |
| 13 | 2019 | 75 | |
| 14 | 2023 | 74 | |
| 15 | 2019 | 71 | |
| 16 | 2019 | 69 | |
| 17 | 2011 | 62 | |
| 18 | 2020 | 48 | |
| 19 | 2010 | 46 | |
| 20 | 2021 | 38 |
About Zhigui Su
Zhigui Su is a scholar working on Biomaterials, Pharmaceutical Science, Biomedical Engineering, Molecular Biology and Rehabilitation, having authored 59 papers that have together received 2.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (28 papers), RNA Interference and Gene Delivery (4 papers), Advanced Drug Delivery Systems (4 papers), Nanoplatforms for cancer theranostics (4 papers), Drug Solubulity and Delivery Systems (2 papers), Vitamin D Research Studies (1 paper), Analytical Methods in Pharmaceuticals (1 paper) and Phagocytosis and Immune Regulation (1 paper). The work is most often cited by research in Biomaterials (846 citations), Drug Discovery (4 citations), Pharmaceutical Science (300 citations), Biomedical Engineering (285 citations) and Molecular Medicine (44 citations). Zhigui Su has collaborated with scholars based in China, Pakistan and Canada. Frequent co-authors include Qineng Neng Ping, Can Zhang, Lingjing Xue, Minjie Sun, Yanyu Xiao, Minglei Chen, Huipeng Li, Yue Wu, Ying Xie and Hongzhi Qiao. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics, Molecular Pharmaceutics, Advanced Materials and European Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.